Rigor prophylaxis in stage IV melanoma and renal cell carcinoma patients treated with high dose IL-2

Overview of attention for article published in BMC Cancer, October 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter: 1 X user

googleplus: 1 Google+ user

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 13 Mendeley

Summary X Google+ Dimensions citations

So far, Altmetric has seen 1 Google+ post.

Melanoma Research, 22 Oct 2018

Rigor prophylaxis in stage IV melanoma and renal cell carcinoma patients treated with high dose IL-2. - PubMed - NCBI BMC Cancer.

This page shows the most recent Google+ posts that mention this research output.

Click here to find out how to access more activity.